Notice of Delisting and Re-Compliance of Nasdaq Listing Rule
- Extendicare Acquires Nine Long-Term Care Homes from Revera - June 2, 2025
- Nxera Pharma to Receive US$15 Million from Neurocrine Biosciences Following Dosing of First Patient in Phase 3 Trial of NBI-1117568 - June 2, 2025
- Discover the Dream Condo for Sale in Summerlin: Under 400k in Las Vegas - June 2, 2025